EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of bradykinin type 2 receptor overexpression on cardiovascular function in mice

Sara Metry, Tatsiana Suvorava, Jens W Fischer, Vu Thao-Vi Dao, Georg Kojda

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2025.117175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Sara Metry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, University Hospital, Heinrich Heine University, Düsseldorf, Germany; Clinical Pharmacy Department, Faculty of Pharmacy, Ai…. Hauptthemen laut MEDLINE: Receptor, Bradykinin B2. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heinrich Heine University Düsseldorf Faculty of Medicine, Heinrich-Heine-Universität Düsseldorf, Deutscher Akademischer Austauschdienst.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bradykinin is an endogenous peptide playing an important role in regulation of vascular function and permeability, but cardiovascular effects of endogenous bradykinin remain incompletely understood. We studied whether genetically engineered overexpression of endothelial bradykinin type 2 receptor (B2) alters cardiac and vascular function using mice with endothelial-specific overexpression of B2 (B2tg) and their transgene-negative littermates (B2n). In the aorta, brain-stem and skeletal muscle of B2tg human BDKRB2 were exclusively expressed, and B2-overexpression was evident by a significant upregulation of B2 protein. Endothelium-dependent aortic relaxation and responses to phenylephrine or the nitric oxide (NO) donor measured ex vivo were unaffected by the transgene. In contrast, bradykinin induced constriction in B2n, but i vasorelaxation in B2tg that was sensitive to inhibition of NO-synthase (NOS). In vivo assessment of endothelial function by flow-mediated dilation revealed no changes in B2tg as compared to B2n. Likewise, transthoracic echocardiography showed no effect of B2 overexpression on cardiac function. In contrast, decreased systolic blood pressure and bradycardia were observed in B2tg. The decrease in blood pressure in B2tg remained following inhibition of cyclooxygenase and NOS, but was completely abolished by the selective B2 antagonist icatibant. Thus, endothelial-specific B2-overexpression induced mild hypotension and bradycardia while having no effect on flow-mediated dilation or several cardiac function parameters. These minor effects of endothelial-specific B2 overexpression in healthy mice suggest that alterations of endogenous bradykinin generation may not be associated with derangements of cardiovascular functions, however, the long-term safety of continuous changes of bradykinin in cardiovascular comorbidities deserves further rigorous clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Bradykinin B2AnimalsMiceBradykininEndothelium, VascularHumansMice, TransgenicVasodilationMaleBlood PressureMice, Inbred C57BL

Stichwörter der Autor:innen

Blood pressureBradykininBradykinin type 2 receptorEchocardiographyFlow-mediated dilation

Substanzen

Receptor, Bradykinin B2Bradykinin

Autor:innen und Institutionen

  • Institute of Pharmacology, University Hospital, Heinrich Heine University, Düsseldorf, Germany; Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
  • Institute of Pharmacology, University Hospital, Heinrich Heine University, Düsseldorf, Germany. Electronic address: T.Suvorava@hhu.de.
  • Institute of Pharmacology, University Hospital, Heinrich Heine University, Düsseldorf, Germany.

Förderung

  • Heinrich Heine University Düsseldorf Faculty of Medicine
  • Heinrich-Heine-Universität Düsseldorf
  • Deutscher Akademischer Austauschdienst
  • Ministry of Higher Education and Scientific Research
  • Deutsche Forschungsgemeinschaft
  • German Academic Exchange Service Cairo

Zitieren

APA

Metry, S., Suvorava, T., Fischer, J. W., Dao, V. T., & Kojda, G. (2025). Impact of bradykinin type 2 receptor overexpression on cardiovascular function in mice. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117175

Vancouver

Metry S, Suvorava T, Fischer JW, Dao VT, Kojda G. Impact of bradykinin type 2 receptor overexpression on cardiovascular function in mice. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117175

BibTeX
@article{Metry2025,
  author = {Metry, Sara and Suvorava, Tatsiana and Fischer, Jens W and Dao, Vu Thao-Vi and Kojda, Georg},
  title = {Impact of bradykinin type 2 receptor overexpression on cardiovascular function in mice},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2025.117175}
}
Kostenlos starten →